Gut check on diabesity: leveraging gut mechanisms for the treatment of type 2 diabetes and obesity
Biological Activity Cagrilintide and semaglutide, when co-administered, produce synergistic reductions in bodyweight (up to ~1517% over 2032 weeks in clinical trials) and significant improvements in glycemic parameters, including HbA1c and fasting glucose
J Nutri Med Diet Care 6:043
Conclusion While combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists holds promise for addressing residual cardiovascular risk in type 2 diabetes, its optimal use requires nuanced consideration of patient subpopulations, safety, and cost-effectiveness
Vitamin C (L-Ascorbic Acid and derivatives): A potent antioxidant, Vitamin C is celebrated for its ability to brighten the complexion, reduce the appearance of dark spots and hyperpigmentation, and protect the skin from environmental damage caused by free radicals
FERONIA: A receptor kinase at the core of a global signaling network